Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Sep;82(9):e205.
doi: 10.1136/ard-2023-223935. Epub 2023 Feb 3.

Correspondence on "ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update"

Juergen Braun  1
Affiliations
Comment

Correspondence on "ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update"

Juergen Braun. Ann Rheum Dis. 2023 Sep.
No abstract available

Keywords: Spondylitis, Ankylosing; Spondyloarthritis; Tumor Necrosis Factors.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Comment in

Comment on

  • 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis.
    van der Heijde D, Ramiro S, Landewé R, Baraliakos X, Van den Bosch F, Sepriano A, Regel A, Ciurea A, Dagfinrud H, Dougados M, van Gaalen F, Géher P, van der Horst-Bruinsma I, Inman RD, Jongkees M, Kiltz U, Kvien TK, Machado PM, Marzo-Ortega H, Molto A, Navarro-Compàn V, Ozgocmen S, Pimentel-Santos FM, Reveille J, Rudwaleit M, Sieper J, Sampaio-Barros P, Wiek D, Braun J. van der Heijde D, et al. Ann Rheum Dis. 2017 Jun;76(6):978-991. doi: 10.1136/annrheumdis-2016-210770. Epub 2017 Jan 13. Ann Rheum Dis. 2017. PMID: 28087505 Review.

References

    1. van der Heijde D, Ramiro S, Landewé R, et al. . 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis 2017;76:978–91. 10.1136/annrheumdis-2016-210770 - DOI - PubMed
    1. Kroon FPB, van der Burg LRA, Ramiro S, et al. . Non-steroidal anti-inflammatory drugs (nsaids) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis). Cochrane Database Syst Rev 2015;2015:CD010952. 10.1002/14651858.CD010952.pub2 - DOI - PMC - PubMed
    1. Dougados M, Gueguen A, Nakache JP, et al. . Ankylosing spondylitis: what is the optimum duration of A clinical study? A one year versus A 6 weeks non-steroidal anti-inflammatory drug trial. Rheumatology (Oxford) 1999;38:235–44. 10.1093/rheumatology/38.3.235 - DOI - PubMed
    1. Ramiro S, Nikiphorou E, Sepriano A, et al. . ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis 2023;82:19–34. 10.1136/ard-2022-223296 - DOI - PubMed
    1. Brandt J, Haibel H, Cornely D, et al. . Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab. Arthritis Rheum 2000;43:1346–52. 10.1002/1529-0131(200006)43:6<1346::AID-ANR18>3.0.CO;2-E - DOI - PubMed